Folgen
Ana Maria Ortega Prieto
Ana Maria Ortega Prieto
Research Associate, Department of Infectious Diseases, King's College London
Bestätigte E-Mail-Adresse bei kcl.ac.uk
Titel
Zitiert von
Zitiert von
Jahr
Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia
L Braga, H Ali, I Secco, E Chiavacci, G Neves, D Goldhill, R Penn, ...
Nature 594 (7861), 88-93, 2021
3992021
3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection
AM Ortega-Prieto, JK Skelton, SN Wai, E Large, M Lussignol, ...
Nature communications 9 (1), 682, 2018
2282018
Human organs-on-chips for virology
H Tang, Y Abouleila, L Si, AM Ortega-Prieto, CL Mummery, DE Ingber, ...
Trends in microbiology 28 (11), 934-946, 2020
1172020
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
L Dupont, LB Snell, C Graham, J Seow, B Merrick, T Lechmere, ...
Nature microbiology 6 (11), 1433-1442, 2021
1052021
Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesis
AM Ortega-Prieto, J Sheldon, A Grande-Pérez, H Tejero, J Gregori, J Quer, ...
PloS one 8 (8), e71039, 2013
842013
Immune evasion strategies during chronic hepatitis B and C virus infection
AM Ortega-Prieto, M Dorner
Vaccines 5 (3), 24, 2017
722017
A Hitchhiker's guide to humanized mice: new pathways to studying viral infections
JK Skelton, AM Ortega‐Prieto, M Dorner
Immunology 154 (1), 50-61, 2018
672018
T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other Flaviviruses
CJ Reynolds, OM Suleyman, AM Ortega-Prieto, JK Skelton, ...
Scientific reports 8 (1), 672, 2018
652018
Identification of broad-spectrum antiviral compounds by targeting viral entry
M Mazzon, AM Ortega-Prieto, D Imrie, C Luft, L Hess, S Czieso, J Grove, ...
Viruses 11 (2), 176, 2019
602019
An overview of vaccines against SARS-CoV-2 in the COVID-19 pandemic era
A Pascual-Iglesias, J Canton, AM Ortega-Prieto, JM Jimenez-Guardeño, ...
Pathogens 10 (8), 1030, 2021
512021
Tissue CD14+CD8+ T cells reprogrammed by myeloid cells and modulated by LPS
LJ Pallett, L Swadling, M Diniz, AA Maini, M Schwabenland, AD Gasull, ...
Nature 614 (7947), 334-342, 2023
472023
Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivation
MJ Lista, PM Matos, TJA Maguire, K Poulton, E Ortiz-Zapater, R Page, ...
PLoS One 16 (9), e0256813, 2021
382021
In Vivo Model Systems for Hepatitis B Virus Research
AM Ortega-Prieto, C Cherry, H Gunn, M Dorner
ACS Infectious Diseases 5 (5), 688-702, 2018
362018
Human Monkeypox: a comprehensive overview of epidemiology, pathogenesis, diagnosis, treatment, and prevention strategies
DE Martínez-Fernández, D Fernández-Quezada, FAG Casillas-Muñoz, ...
Pathogens 12 (7), 947, 2023
31*2023
" Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
AM Ortega-Prieto, JK Skelton, C Cherry, MA Briones-Orta, CA Hateley, ...
Journal of Visualized Experiments (JoVE), e58333, 2019
282019
Hypoxic gene expression in chronic hepatitis B virus infected patients is not observed in state-of-the-art in vitro and mouse infection models
PJ Liu, JM Harris, E Marchi, V D’arienzo, T Michler, PAC Wing, A Magri, ...
Scientific Reports 10 (1), 14101, 2020
182020
Phosphodiesterase-induced cAMP degradation restricts hepatitis B virus infection
AA Evripioti, AM Ortega-Prieto, JK Skelton, Q Bazot, M Dorner
Philosophical Transactions of the Royal Society B 374 (1773), 20180292, 2019
142019
Drug repurposing based on a quantum-inspired method versus classical fingerprinting uncovers potential antivirals against SARS-CoV-2
JM Jimenez-Guardeño, AM Ortega-Prieto, B Menendez Moreno, ...
PLoS computational biology 18 (7), e1010330, 2022
132022
Development of a structural epitope mimic: An idiotypic approach to HCV vaccine design
VM Cowton, AM Owsianka, V Fadda, AM Ortega-Prieto, SJ Cole, JA Potter, ...
npj Vaccines 6 (1), 1-10, 2021
132021
3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection. Nat Commun 9: 682
AM Ortega-Prieto, JK Skelton, SN Wai, E Large, M Lussignol, ...
122018
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20